Q2 2025 Holdings
Filed 2025-08-14 | 17 holdings | $771.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $89.0M | 2,048,647 | 11.5% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $85.1M | 815,176 | 11.0% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $74.5M | 3,711,444 | 9.6% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $64.6M | 1,824,031 | 8.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $60.2M | 4,018,101 | 7.8% |
| Nuvalent Inc(NUVL) | COM | 670703107 | $55.5M | 727,563 | 7.2% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $50.4M | 2,707,191 | 6.5% |
| Kiniksa Pharmaceuticals Intl(KNSA) | ORD SHS CL A | G52694109 | $49.1M | 1,772,839 | 6.4% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $48.4M | 3,459,913 | 6.3% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $44.7M | 6,225,641 | 5.8% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $37.8M | 3,371,922 | 4.9% |
| Jade Biosciences Inc(JBIO) | COM NEW | 008064206 | $32.2M | 3,220,368 | 4.2% |
| Crescent Biopharma Inc.(CBIO) | COM | G2545C104 | $22.4M | 1,387,866 | 2.9% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $19.1M | 3,554,129 | 2.5% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $18.3M | 1,892,806 | 2.4% |
| Inhibikase Therapeutics Inc(IKT) | COM NEW | 45719W205 | $11.9M | 6,125,000 | 1.5% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $8.8M | 3,896,582 | 1.1% |